Ubavitinib
AZD3229 is a potent pan-KIT mutant inhibitor for the treatment of gastrointestinal stromal tumors. AZD3229 inhibits c-KIT with an IC50 value of 223.3 nM[1][2].
Product Specifications
CAS Number
2248003-60-1
Product Name Alternative
AZD3229
UNSPSC
12352005
Target
C-Kit
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/AZD3229.html
Purity
99.69
Solubility
DMSO : 40 mg/mL (ultrasonic)
Smiles
COCCOC1=CC(F)=C2C(N=CN=C2NC3=CC=C(NC(CN4C=C(C(C)C)N=N4)=O)C=C3)=C1
Molecular Formula
C24H26FN7O3
Molecular Weight
479.51
References & Citations
[1]Kettle JG, et al. Discovery of N- (4-{[5-Fluoro-7- (2-methoxyethoxy) quinazolin-4-yl]amino} phenyl) -2-[4- (propan-2-yl) -1 H-1,2,3-triazol-1-yl]acetamide (AZD3229), a Potent Pan-KIT Mutant Inhibitor for the Treatment of Gastrointestinal Stromal Tumors. J Med Chem. 2018 Oct 11;61 (19) :8797-8810.|[2]Ryu H, et.al. Antitumor Activity of a Novel Tyrosine Kinase Inhibitor AIU2001 Due to Abrogation of the DNA Damage Repair in Non-Small Cell Lung Cancer Cells. Int J Mol Sci. 2019 Sep 24;20 (19) :4728.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
HP217269 200 Reactions
Calpain 12 (CAPN12) Human qPCR Primer Pair (NM_144691)
Sign In for Pricing
View Details 
